Nerve Transfer Reconstruction in the Tetraplegic Upper Extremity
Early Nerve Reconstruction Approach in Tetraplegic Patients With Dysfunctional Upper Extremity: a Randomized Controlled Trial.
1 other identifier
interventional
10
1 country
1
Brief Summary
The cervical spine is most commonly injured, accounting for 53.4% of spinal injuries. More than 40% of all spinal injuries occur at either C4, C5 or C6 levels leading to variable loss of function in the upper extremities. Traditionally, patients sustaining a cervical spine injury were followed for 2 years to ensure that recovery had stabilized before offering upper extremity reconstruction. This type of reconstruction includes active muscle transfer, tendon transfer and joint fusion. Patients are most commonly assessed immediately at the time of injury. Muscle testing is commonly performed using Medical Research Grading System (MRC). Although complete neurologic stabilization may not be complete until 2 years post-injury, in the group with initial grade 0 muscle strength after the acute phase of injury, expectations of improved muscle strength to or beyond grade 3 after 4-6 months is minimal. And grade 3 muscle strength is felt to be the minimum useful functional strength in a muscle group. The investigators propose an early nerve reconstruction approach to the tetraplegic patient with dysfunction of the upper extremity to augment the available tendon transfers. A comparative pilot study is proposed to determine the effectiveness of supinator branch to posterior interosseous nerve (PIN) transfer in 5 patients with cervical spine injury. Patient who fits inclusion criteria will be offered the opportunity to be involved in the study and reviewed at 6 months from injury. If the patient still has not regained Grade 3 power in finger or thumb extension, they will be randomized to be in a surgical group or non-surgical group. If informed consent is obtained, then surgery will be completed between 6-9 months from the patient's original cervical spine injury. The patient will be followed at regular intervals post-operatively with expectation of 18-24 month follow-up. Measures will be used pre and post-operatively for comparison. Measures will include MRC muscle grade (EDC), range of motion, Disability of the Arm, Shoulder, and Hand Questionnaire (DASH), and The Graded Redefined Assessment of Strength Sensibility and Prehension (GRASSP) (Kalsi-Ryan, 2011).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_4
Started Jun 2012
Longer than P75 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 22, 2012
CompletedFirst Posted
Study publicly available on registry
April 18, 2012
CompletedStudy Start
First participant enrolled
June 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2019
CompletedFebruary 6, 2018
February 1, 2018
7.5 years
March 22, 2012
February 2, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Medical Research Grading (MRC) System
A grading system testing the strength of muscles and ranging from grade 0 (weakest) to grade 5 (strongest).
Baseline (before surgery)
Medical Research Grading (MRC) System
A grading system testing the strength of muscles and ranging from grade 0 (weakest) to grade 5 (strongest).
9 months post-op
Medical Research Grading (MRC) system
A grading system testing the strength of muscles and ranging from grade 0 (weakest) to grade 5 (strongest).
12 months post-op
Medical Research Grading (MRC) system
A grading system testing the strength of muscles and ranging from grade 0 (weakest) to grade 5 (strongest).
24 months post-op
Secondary Outcomes (7)
Range of motion
Baseline (before surgery)
Range of motion
9 months post-op
Range of motion
12 months post-op
Range of motion
24 months post-op
DASH questionnaire
Baseline (before surgery)
- +2 more secondary outcomes
Study Arms (2)
Surgical arm
EXPERIMENTALNerve reconstruction: Early nerve transfer (around 6-9 months post cervical spine injury) will be performed in this group of patients.
Non-surgical (or observed)
NO INTERVENTIONPatients in this group will receive standard of care and be observed for up to two years post injury.
Interventions
Under general anesthetic, the surgeon will make a cut on the back (dorsal) part of the forearm. The radial nerve will be identified and specifically the branches which control the supinator muscle and the remainder of the radial nerve (Posterior interosseous nerve or PIN). . The PIN branch will be stimulated to ensure that it is non-functional. Then, the supinator branch will be stimulated to ensure it is functioning and is appropriate for transfer. If appropriate, the supinator branch will be severed and connected to the EDC branch under the operating room microscope. After the surgery, the patient will be placed into a splint including the forearm and hand for 2-3 weeks.
Eligibility Criteria
You may qualify if:
- Cervical spine injury with functional loss in the upper extremity
- Greater than 4 months out from C-spine injury
- Stable motor recovery
- Medically stable
- International Classification for Surgery of the Hand in Tetraplegia of 0-5 at 6 months
- Grade 0 finger/thumb extension at 6 months
- Subjects fluent in English or when not fluent, an appropriate translator is present
You may not qualify if:
- Unstable patient
- Joint contracture
- Spasticity
- Loss of function is expected to be improved by reliable tendon transfer, tenodesis or arthrodesis that is available
- Evidence of recovering finger/thumb extension at 4-6 months
- Greater than 12 months from spinal cord injury
- Subject not fluent in English or an appropriate translator not available
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Vancouver General Hospital
Vancouver, British Columbia, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sean Bristol, MD
University of British Columbia
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 22, 2012
First Posted
April 18, 2012
Study Start
June 1, 2012
Primary Completion
December 1, 2019
Study Completion
December 1, 2019
Last Updated
February 6, 2018
Record last verified: 2018-02